Avicanna Inc (TO:AVCN) — Market Cap & Net Worth
Market Cap & Net Worth: Avicanna Inc (AVCN)
Avicanna Inc (TO:AVCN) has a market capitalization of $13.17 Million (CA$18.21 Million) as of May 2, 2026. Listed on the TO stock exchange, this Canada-based company holds position #26195 globally and #1072 in its home market, demonstrating a -3.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avicanna Inc's stock price CA$0.15 by its total outstanding shares 125557263 (125.56 Million). Analyse how efficiently does Avicanna Inc generate cash to see how efficiently the company converts income to cash.
Avicanna Inc Market Cap History: 2019 to 2026
Avicanna Inc's market capitalization history from 2019 to 2026. Data shows change from $230.70 Million to $13.17 Million (-42.52% CAGR).
Avicanna Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avicanna Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.80x
Avicanna Inc's market cap is 0.80 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $230.70 Million | $168.25K | -$22.21 Million | 1371.15x | N/A |
| 2020 | $118.98 Million | $1.57 Million | -$32.86 Million | 75.78x | N/A |
| 2021 | $70.84 Million | $3.27 Million | -$16.77 Million | 21.67x | N/A |
| 2022 | $37.24 Million | $4.05 Million | -$14.73 Million | 9.20x | N/A |
| 2023 | $31.79 Million | $16.79 Million | -$8.74 Million | 1.89x | N/A |
| 2024 | $27.70 Million | $25.46 Million | -$3.62 Million | 1.09x | N/A |
| 2025 | $20.44 Million | $25.48 Million | -$2.84 Million | 0.80x | N/A |
Competitor Companies of AVCN by Market Capitalization
Companies near Avicanna Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Avicanna Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Avicanna Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Avicanna Inc's market cap moved from $230.70 Million to $ 13.17 Million, with a yearly change of -42.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$13.17 Million | -35.56% |
| 2025 | CA$20.44 Million | -26.23% |
| 2024 | CA$27.70 Million | -12.86% |
| 2023 | CA$31.79 Million | -14.63% |
| 2022 | CA$37.24 Million | -47.44% |
| 2021 | CA$70.84 Million | -40.46% |
| 2020 | CA$118.98 Million | -48.43% |
| 2019 | CA$230.70 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Avicanna Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.17 Million USD |
| MoneyControl | $13.17 Million USD |
| MarketWatch | $13.17 Million USD |
| marketcap.company | $13.17 Million USD |
| Reuters | $13.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Avicanna Inc
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with vari… Read more